Liminal Biosciences Inc (LMNL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,571 | 86,564 | 33,649 | 46,184 | 5,701 |
| Receivables | 905 | 852 | 3,047 | 10,023 | 15,409 |
| Inventories | N/A | N/A | 7,000 | 5,676 | 9,280 |
| TOTAL | $31,782 | $91,463 | $54,509 | $71,479 | $31,510 |
| Non-Current Assets | |||||
| PPE Net | 3,341 | 4,375 | 14,028 | 16,181 | 31,719 |
| Intangibles | 2,492 | 2,805 | 11,565 | 10,434 | 15,278 |
| Other Non-Current Assets | 1,198 | 1,935 | 7,825 | 26,324 | 875 |
| TOTAL | $7,031 | $9,115 | $33,417 | $52,939 | $47,872 |
| Total Assets | $38,813 | $100,578 | $87,926 | $124,418 | $79,381 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 124 | 2,477 |
| Accounts payable and accrued liabilities | 4,591 | 5,859 | 12,567 | 17,188 | 24,576 |
| Other current liabilities | 2,615 | 3,157 | N/A | N/A | 121 |
| TOTAL | $7,771 | $14,756 | $17,753 | $23,560 | $27,566 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 30,568 | 30,257 | 6,533 | 94,581 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 391 |
| Other Non-Current Liabilities | 2,518 | 16,564 | 9,544 | 1,002 | 37,206 |
| TOTAL | $3,191 | $58,788 | $58,967 | $29,316 | $100,533 |
| Total Liabilities | $10,962 | $73,544 | $76,719 | $52,876 | $128,098 |
| Shareholders' Equity | |||||
| Common Shares | 753,700 | 781,822 | 729,525 | 703,072 | 449,875 |
| Retained earnings | -832,506 | -857,078 | -811,482 | -728,770 | -583,013 |
| Other shareholders' equity | 71,295 | 67,095 | 63,395 | 64,434 | 67,508 |
| TOTAL | $27,851 | $27,034 | $11,207 | $71,542 | $-48,717 |
| Total Liabilities And Equity | $38,813 | $100,578 | $87,926 | $124,418 | $79,381 |